Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration - Wikidata - wikimedia - TriplyDB

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

http://www.wikidata.org/entity/Q28513873

about

Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases Microglia centered pathogenesis in ALS: insights in cell interconnectivity Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse Age-Related Changes in Pre- and Postsynaptic Partners of the Cholinergic C-Boutons in Wild-Type and SOD1G93A Lumbar Motoneurons Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.Selective degeneration of a physiological subtype of spinal motor neuron in mice with SOD1-linked ALS Early detection of structural abnormalities and cytoplasmic accumulation of TDP-43 in tissue-engineered skins derived from ALS patients Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca(2+) transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice.Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade.Disease mechanisms and therapeutic approaches in spinal muscular atrophy.Spinal Glia Division Contributes to Conditioning Lesion-Induced Axon Regeneration Into the Injured Spinal Cord: Potential Role of Cyclic AMP-Induced Tissue Inhibitor of Metalloproteinase-1 Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.Potassium currents dynamically set the recruitment and firing properties of F-type motoneurons in neonatal mice An in vivo screen to identify candidate neurogenic genes in the developing Xenopus visual system.Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases.Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9.MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.Progression of motor neuron disease is accelerated and the ability to recover is compromised with advanced age in rNLS8 mice A(a)LS: Ammonia-induced amyotrophic lateral sclerosis.Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal Muscles Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).The phenotypic variability of amyotrophic lateral sclerosis.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS.

P2860

Q26779933-6D545A8F-B4FA-498A-9933-99D73859C050 Q27009559-D288AC0E-C8BA-4D32-9924-F27FF5A64D58 Q27340373-6FC84300-51B0-4487-A54E-D0048105FF7B Q28547452-08FE03C8-8317-4169-9DC5-5C8107C69E55 Q30830145-6ACC21D1-958E-4625-B323-825C1EDAB2A0 Q33638307-80CCBB2B-38E2-454C-90BB-F68196618BBA Q33665800-007EA47D-2186-4D8B-BACB-48C05CA778E5 Q34315397-B9602FBE-5BE9-42D5-8598-9C5A33677DCE Q34601264-9A9C6C61-5F46-4F8B-9927-8AE65F78C803 Q35176790-2A425453-3FAE-4CA4-B0E3-32656A6DA59C Q35365484-B0A7D78B-BD27-485F-B856-CF964837E58D Q35453975-FE796290-E692-4EAB-B95E-12B559B55533 Q35469175-99A4B2B5-B8F5-4847-AB8A-85362F09EAB6 Q35549144-FEE5BD20-5240-4DB1-A260-0E54BF965A52 Q35707832-AAA63CB8-3637-4DCE-896A-66FDB16FEEA3 Q35748916-C607692B-5D96-49F5-850C-A33212EA6685 Q35818695-F18DB20B-B0DD-4265-AA87-38BD7D054E6D Q36061996-1AE4E04B-62F6-4497-8294-3B691777DE19 Q36084199-BAB12ABB-94DB-49D0-855C-E6E5DE33D6B2 Q36096105-889818AA-EC6A-47FD-959B-B2AD70CAA9A2 Q36329972-88F43214-52A7-4B6A-9312-451EBF0996DD Q36343836-62B10D4F-5A17-401B-B30F-6E6D06442DE7 Q36903049-8527BE33-14BD-4EA9-A38A-512F0F8DF03C Q36970239-05B21655-B617-425B-A3E5-80811D08ABFE Q37274907-C4272392-FF50-4071-B812-15E87F7C317D Q37299299-40A05686-BA55-40DA-8A3C-7E99D9FB98BC Q37337058-2BDD4F7D-99BA-4F71-8DFD-FC2B28FE25CE Q37534101-B914118C-DE37-4013-B508-19B23704A82A Q37589790-96B0A90B-CD7D-43B2-B69F-078F173CF7DC Q38232360-ED5D7506-FD71-4C50-8E5B-8126D5F685D8 Q38259758-539EB945-C863-4E64-8747-8BDFF171CC26 Q38573829-FF68DB66-FAD4-403D-B059-EDA8610A67E5 Q38622769-50E3A2BE-E63B-4751-BAAF-341F9107D5F0 Q38634770-F6587405-200C-4684-8D11-D9CEEB92693B Q38670015-1757FA52-16D3-40F7-A739-E402AA0544B0 Q38765043-26FB9241-21EA-43BD-ABC9-2DF5E1674048 Q38902929-753FED27-32F0-4910-ACC9-845C080706DB Q38955746-DD05830C-FBCF-4D47-8A57-AC9C9BC8A0E5 Q41009555-3EF01C41-D815-41DB-B3DE-D80C8690C88D Q41596941-A51779B3-301A-4175-9F1E-F7B27D6B4C2A

P2860

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

http://www.wikidata.org/entity/Q28513873

description

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2014

@ast

im Januar 2014 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2014/01/22)

@sk

vědecký článek publikovaný v roce 2014

@cs

wetenschappelijk artikel (gepubliceerd op 2014/01/22)

@nl

наукова стаття, опублікована в січні 2014

@uk

مقالة علمية (نشرت في 22-1-2014)

@ar

name

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@ast

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@en

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@nl

type

label

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@ast

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@en

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@nl

prefLabel

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@ast

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@en

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@nl

P1433

Q28513873-2BA5519D-D773-46A6-814A-A377CE6C503E

P1476

Q28513873-BF74297F-4CB6-4791-8384-85CBC8DEAEB3

P2093

Q28513873-05EB74FC-51DA-40BB-ABB4-BD77D7B9F764

Q28513873-28348332-B180-4DD4-8913-889204C5BBA6

Q28513873-348298B4-02FE-4B41-A946-4069C10F844B

Q28513873-644FF540-432D-4896-B0A7-1D4908F89B04

Q28513873-AC0C558D-62F1-45B3-988C-F13724F7C351

Q28513873-CB7C05C3-26F1-45C6-BACA-367D6E7D9E60

P2860

Q28513873-09F0A72F-0757-47DC-AECF-0BFC9311077F

Q28513873-13718A0D-D2C2-4F4B-9816-EC5FE078FC9A

Q28513873-1ED57C29-A876-4A01-A4D8-36B1950DF396

Q28513873-2A4665B4-FE09-4A3F-87AB-1F322260393F

Q28513873-305673AE-E161-473D-A818-6BF80734D15B

Q28513873-3190BBD0-C11C-410B-94BB-C03353C04EAB

Q28513873-32B130AF-98C6-4974-A9A3-7169CE70EB5B

Q28513873-4788A3E8-5E8E-4B83-B9F6-6069FFF8006C

Q28513873-4A8A7571-2767-4FEA-9A45-EF2E4B6EF50B

Q28513873-4BF74AAF-8856-441F-B721-B62369DE265A

P304

Q28513873-2C50AE5F-1ABD-4EEA-82AA-029875C98F31

P31

Q28513873-6E71EF9F-05E7-47A8-A3A7-A44A29368393

P3181

Q28513873-4330A742-5942-42B9-8B61-2581E3F1A378

P356

Q28513873-430F43CA-5E7E-48EE-A587-A8FB96DE1648

P407

Q28513873-068E807F-460C-46F9-AFC3-682DC2015CA1

P433

Q28513873-BC8474C1-5BF6-4BB5-93AE-EE3DB2FF55AF

P478

Q28513873-938E235F-75DE-432C-9EBF-D284BB013A8F

P50

Q28513873-74AE813D-A51D-405B-AA18-AC5586F62878

Q28513873-7D624C84-919F-434C-86CD-819EB7CBA981

Q28513873-E2C61E1B-837E-4210-924D-7384C5227206

P577

Q28513873-803B09EB-A13C-4493-BE7E-BA9C02CC471B

P5875

Q28513873-F3809E0D-D113-4AFA-802C-D61E8E7CCD83

P698

Q28513873-B273F1A8-99AE-4847-9FE3-ABEFDC816B99

P932

Q28513873-1DE6C4D2-3475-4C79-9446-7B5DBED9447F

P3181

P356

J.NEURON.2013.12.009

P1433

P1476

Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration

@en

P2093

Artem Kaplan

http://www.w3.org/2001/XMLSchema#string

Christopher E Henderson

http://www.w3.org/2001/XMLSchema#string

Christopher Towne

http://www.w3.org/2001/XMLSchema#string

Ginn T Choe

http://www.w3.org/2001/XMLSchema#string

Kevin C Kanning

http://www.w3.org/2001/XMLSchema#string

Patrick Aebischer

http://www.w3.org/2001/XMLSchema#string

P2860

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

Gamma and alpha motor neurons distinguished by expression of transcription factor Err3

Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade

Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory.

Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival.

Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.

Identification of novel spinal cholinergic genetic subtypes disclose Chodl and Pitx2 as markers for fast motor neurons and partition cells.

P304

333-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1007635

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.NEURON.2013.12.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Krista J Spiller

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259916758

http://www.w3.org/2001/XMLSchema#string

P698

24462097

http://www.w3.org/2001/XMLSchema#string

P932

6015650

http://www.w3.org/2001/XMLSchema#string